Indication
Chronic Inflammatory Demyelinating Polyneuropathy
The Chronic Inflammatory Demyelinating Polyneuropathy pipeline: 1 tracked drug.
Coverage in progress.The assets here come from their companies' published pipelines. AssetMemo has not yet run its full census of every drug in development for Chronic Inflammatory Demyelinating Polyneuropathy, so this list is not complete.
1 Phase 2
Market size not yet sourced. How markets are sized ↗